Form 4: Milestone Scientific Director and 10% Owner BP4 S.r.l. Sells Over 11,000 Shares

BP4 S.r.l., a significant shareholder and director of Milestone Scientific Inc., reported the sale of 11,749 shares of common stock across two transactions in mid-June 2025.

Summary

• BP4 S.r.l., identified as a Director and 10% Owner of Milestone Scientific Inc. (MLSS), reported two separate sales of the company's common stock.
• On June 16, 2025, BP4 S.r.l. sold 10,056 shares of Common Stock at a price of $0.8951 per share.
• Following this transaction, BP4 S.r.l.'s beneficial ownership stood at 9,447,183 shares.
• Two days later, on June 18, 2025, an additional 1,693 shares of Common Stock were sold at a price of $0.88 per share.
• After the second transaction, BP4 S.r.l.'s beneficial ownership decreased to 9,445,490 shares.
• The total number of shares sold by BP4 S.r.l. across both reported transactions amounts to 11,749 shares.

Sentiment

Score: 3

Explanation: The sale of shares by a significant insider (10% owner and director) is generally viewed as a negative signal, indicating a reduction in their stake and potentially a lack of confidence or a need for liquidity. While the number of shares sold is relatively small compared to their total holdings, any insider selling can create negative sentiment.

Negatives

• A significant shareholder and director, BP4 S.r.l., reduced its stake in Milestone Scientific Inc. by selling a total of 11,749 shares of common stock.
• The sales occurred at prices of $0.8951 and $0.88 per share, which could be interpreted as a lack of confidence or a move to liquidate holdings by a key insider.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider transaction, which is a routine disclosure for publicly traded companies. While the filing itself does not provide broader industry context, insider selling by a significant shareholder and director can sometimes be interpreted by the market as a signal regarding the company's near-term prospects or valuation within its sector.

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative signal, potentially leading to decreased investor confidence or downward pressure on the stock price.

Key Dates

Recommendation

Keywords

Milestone Scientific Inc., MLSS, BP4 S.r.l., SEC Form 4, Insider Selling, Stock Sale, Beneficial Ownership, Director Transaction, 10% Owner